台湾口腔癌患者临终医疗支出决定因素：一项基于人群的研究

数据集获取（Figshare）

• 源站标题：Determinants of End-of-Life Expenditures in Patients with Oral Cancer in Taiwan: A Population-Based Study
• DOI：10.1371/journal.pone.0126482
• 发布日期：2015-05-06
• 文件数：2 个
• 文件总体积：1.71 MB
• 源站页面：https://plos.figshare.com/articles/dataset/_Determinants_of_End_of_Life_Expenditures_in_Patients_with_Oral_Cancer_in_Taiwan_A_Population_Based_Study_/1406678

命令行下载

curl -L -o "S1_Fig.tif" "https://ndownloader.figshare.com/files/2057200"
curl -L -o "S2_Fig.tif" "https://ndownloader.figshare.com/files/2057201"

文件清单

• S1_Fig.tif（812.80 KB）
• S2_Fig.tif（900.91 KB）

文件总体积 1.71 MB（源站 API 实测）。

数据说明

Background
To investigate the association of basic demographic data, socioeconomic status, medical services, and hospital characteristics with end-of-life expenditure in patients with oral cancer in Taiwan who died between 2009 to 2011.
Methods
This nationwide population-based, retrospective cohort study identified 5,386 patients who died from oral cancer. We evaluated medical cost in the last month of life by universal health insurance. The impact of each variable on the end-of-life expenditure was examined by hierarchical generalized linear model (HGLM) using a hospital-level random-intercept model.
Results
The mean medical cost in the last six months of life was $2,611±3,329 (U.S. dollars). In HGLM using a random-intercept model, we found that patients younger than 65 years had an additional cost of $819 over those aged ≥65 years. Patients who had a high Charlson Comorbidity Index Score (CCIS) had an additional $616 cost over those with a low CCIS. Those who survived post-diagnosis less than 6 months had an additional $659 in expenses over those who survived more than 24 months. Medical cost was $249 more for patients who had medium to high individual SES, and $319 more for those who were treated by non-oncologists.
Conclusion
This study provides useful information for decision makers in understanding end-of-life expenditure in oral cancer. We found significantly increased end-of-life expenditure in patients if they were younger than 65 years or treated by non-oncologists, or had high CCIS, medium to high individual SES, and survival of less than 6 months after diagnosis.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0126482（source: https://plos.figshare.com/articles/dataset/_Determinants_of_End_of_Life_Expenditures_in_Patients_with_Oral_Cancer_in_Taiwan_A_Population_Based_Study_/1406678）。